# The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025, Regulation 18: Amendment to regulation 29

Extent: E+W+S+N.I.

(1) Regulation 29 (conduct of trial in accordance with clinical trial authorisation etc.) is amended as follows.
(2) In paragraphs (a) and (b)—
(a) for “amended” substitute “modified”;
(b) for “regulations 22 to 25” substitute “regulations 20 to 22C”.
(3) In paragraph (c)—
(a) omit “by the licensing authority”;
(b) for “regulation 18(2) or (6), 19(8), 20(5), 24(5)” substitute “regulation 18(3), 18B(3), 22A(4), 22C(3)”.

---
Source: https://www.legislation.gov.uk/uksi/2025/538/regulation/18 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-amendment-regulations-2025/regulation-18
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.